BTK targeting resulted in the inhibition of genes belonging to the MCL_R16 signature, including BCL2A1, in CARD11WT but not in CARD11MUT cells (P < .0001; Figure 7A left panel). In contrast, MALT1 inhibition similarly lowered gene expression in both groups including BCL2A1, which was ...